Potent Anti-SARS-CoV-2 Efficacy of COVID-19 Hyperimmune Globulin from Vaccine-Immunized Plasma.

Coronavirus disease 2019 (COVID-19) remains a global public health threat. Hence, more effective and specific antivirals are urgently needed. Here, COVID-19 hyperimmune globulin (COVID-HIG), a passive immunotherapy, is prepared from the plasma of healthy donors vaccinated with BBIBP-CorV (Sinopharm COVID-19 vaccine). COVID-HIG shows high-affinity binding to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein, the receptor-binding domain (RBD), the N-terminal domain of the S protein, and the nucleocapsid protein; and blocks RBD binding to human angiotensin-converting enzyme 2 (hACE2). Pseudotyped and authentic virus-based assays show that COVID-HIG displays broad-spectrum neutralization effects on a wide variety of SARS-CoV-2 variants, including D614G, Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Kappa (B.1.617.1), Delta (B.1.617.2), and Omicron (B.1.1.529) in vitro. However, a significant reduction in the neutralization titer is detected against Beta, Delta, and Omicron variants. Additionally, assessments of the prophylactic and treatment efficacy of COVID-HIG in an Adv5-hACE2-transduced IFNAR-/- mouse model of SARS-CoV-2 infection show significantly reduced weight loss, lung viral loads, and lung pathological injury. Moreover, COVID-HIG exhibits neutralization potency similar to that of anti-SARS-CoV-2 hyperimmune globulin from pooled convalescent plasma. Overall, the results demonstrate the potential of COVID-HIG against SARS-CoV-2 infection and provide reference for subsequent clinical trials.

[Selective breeding research on new cultivar "ChuanPeng 1" of Curcuma phaeocaulis].

OBJECTIVE: To breed a new good cultivar of Curcuma phaeocaulis. METHODS: Three rounds of selection were systematically made for screening the new cultivar using biological technology. Firstly, individual plant selection. Promising individual plant selection was made based on the thousands of Curcuma phaeocaulis resources collected from all over the country. Secondly, strain selection. The promising strain was selected continually from the superior individuals on basis of specificities such as biological characteristics, yield, content of volatile oil and resistance. Thirdly, strain comparison test. The superior strain was selected through strain trial and regional trial. RESULTS: For the new cultivar "ChuanPeng 1" , its main rhizome was in ovoid or spindle shape, and it was fleshy and corpulent. Average amount of rhizome was 4, with 6. 27 cm in length and 3. 37 cm in diameter, while the secondary roots were cylindrical-like, with a yellow green cross section as the main rhizome. Slender root ends were inflated into the fleshy spindle shape, average amount of whose was 25, 3. 20 cm in length and 1. 33 cm in diameter with a yellow green or near white cross section. Average yield of rhizome is 5 314. 5 kg/hm2, while the root is 1 942. 5 kg/hm2, which was 32. 9% and 22. 7% higher than the local main cultivar respectively. The average extract content of rhizome was 15. 41% and content of volatile oil was 2. 82%, which was 15. 60% and 9. 30% higher than the local cultivar respectively. CONCLUSION: " ChuanPeng 1" has good stability and strong adaptability with high yield and superior internal quality. It can be cultivated and promoted in Jinma River Valley,Sichuan.

[HPA distribution characteristics of platelet donor population in Mudanjiang area of China and establishment of its database].

This study was aimed to explore the distribution characteristics of the human platelet antigen (HPA) gene of human platelet donors and its polymorphism in Mudanjiang area of Heilongjiang Province in China, to determine platelet antigen system with clinical significance by judging the rate of incompatibility of HPA, as well as to establish a database of donors' HPA. The genotyping of 154 unrelated platelet donors was performed by means of PCR-SSP. The frequencies of gene and genotype were calculated and compared with that in other areas. The results showed that the genes 1a-17a of HPA-a were all expressed in the 154 healthy and unrelated platelet donors. Only genes 1b, 2b, 3b, 5b, 6b and 15b of HPA-b were expressed while genes 4b, 7b-14b, 16b were not expressed. Among the genotypes, aa homozygosity was predominant and HPA15 had the greatest heterozygosity, while HPA3 had lower heterozygosity. There were 23 combined types of HPA, 5 of them had a rate higher than 10%, and the frequencies of the other 18 were lower than 8%. HPA genotype frequencies showed a good consistency to Hardy-Weinberg equilibrium. It is concluded that the distribution of the allele polymorphism of HPA1-HPA17 in Mudanjiang area has its own characteristics, compared with other areas and some countries, the local HPA genotype database of platelet donors is established in Mudanjiang area, which can provide the matching donors for clinical use with immunological significance.